E. Jones

发表

Antibody responses to SARS-CoV-2 vaccines in 45,965 adults from the general population of the United Kingdom

D. Stuart, K. Lythgoe, D. Bonsall, 2021, Nature Microbiology.

Antibody responses and correlates of protection in the general population after two doses of the ChAdOx1 or BNT162b2 vaccines

Paul J. Birrell, K. Lythgoe, D. Bonsall, 2022, Nature Medicine.

SARS-CoV-2 anti-spike IgG antibody responses after second dose of ChAdOx1 or BNT162b2 in the UK general population

D. Stuart, T. Peto, B. Marsden, 2021, medRxiv.

COVID‐19 in pregnancy—characteristics and outcomes of pregnant women admitted to hospital because of SARS‐CoV‐2 infection in the Nordic countries

M. Gissler, K. Klungsøyr, P. Juliusson, 2021, medRxiv.

Quantitative SARS-CoV-2 anti-spike responses to Pfizer–BioNTech and Oxford–AstraZeneca vaccines by previous infection status

D. Stuart, T. Walker, A. Walker, 2021, Clinical Microbiology and Infection.

Effects of N‐butyldeoxynojirimycin and the Lec3.2.8.1 mutant phenotype on N‐glycan processing in Chinese hamster ovary cells: Application to glycoprotein crystallization

D. Stuart, K. Harlos, T. Butters, 1999, Protein science : a publication of the Protein Society.

Recognition surfaces of MHC class I

D. Stuart, J. Tormo, S. Reid, 1998, Immunological reviews.

The Duration, Dynamics, and Determinants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Responses in Individual Healthcare Workers

G. Rodger, M. Gates, J. Dequaire, 2021, Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America.

A functional and structural basis for TCR cross-reactivity in multiple sclerosis

Arne Svejgaard, Lars Madsen, Lars Fugger, 2002, Nature Immunology.

Anti-spike antibody response to natural SARS-CoV-2 infection in the general population

A. Walker, T. Peto, D. Crook, 2021, medRxiv.

SARS-CoV-2 antibody trajectories after a single COVID-19 vaccination with and without prior infection

K. Lythgoe, D. Bonsall, T. House, 2022, Nature Communications.

The challenge of limited vaccine supplies: impact of prior infection on anti-spike IgG antibody trajectories after a single COVID-19 vaccination

D. Stuart, T. Peto, D. Crook, 2021, medRxiv.

An Observational Cohort Study on the Incidence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and B.1.1.7 Variant Infection in Healthcare Workers by Antibody and Vaccination Status

Eleanor L. Ross, G. Rodger, S. Jarvis, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Symptoms and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Positivity in the General Population in the United Kingdom

K. Lythgoe, D. Bonsall, T. House, 2021, Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America.

Protection against SARS-CoV-2 Omicron BA.4/5 variant following booster vaccination or breakthrough infection in the UK

Paul J. Birrell, K. Lythgoe, D. Bonsall, 2023, Nature communications.

Quantitative SARS-CoV-2 anti-spike responses to Pfizer-BioNTech and Oxford-AstraZeneca vaccines by previous infection status

D. Stuart, T. Walker, A. Walker, 2021, medRxiv.

The impact of SARS-CoV-2 vaccines on antibody responses in the general population in the United Kingdom

D. Stuart, J. Farrar, I. Diamond, 2021, medRxiv.

Anti-spike antibody response to natural SARS-CoV-2 infection in the general population

K. Lythgoe, D. Bonsall, T. House, 2021, Nature Communications.

Structure and dimerization of a soluble form of B7-1.

D I Stuart, E Y Jones, K Harlos, 2000, Immunity.

Structure of the brain-derived neurotrophic factor/neurotrophin 3 heterodimer.

D. Stuart, R. Robinson, E. Jones, 1995, Biochemistry.

The Human Low Affinity Fcγ Receptors IIa, IIb, and III Bind IgG with Fast Kinetics and Distinct Thermodynamic Properties*

David I. Stuart, D. Stuart, E. Jones, 2001, The Journal of Biological Chemistry.

Structural Plasticity of Eph Receptor A4 Facilitates Cross-Class Ephrin Signaling

R. Owens, D. Stuart, E. Jones, 2009, Structure.

Structural basis for the recognition of hydroxyproline in HIF-1α by pVHL

Christopher J. Schofield, David I. Stuart, Timothy D. W. Claridge, 2002, Nature.

3'-Azido-3'-deoxythymidine drug resistance mutations in HIV-1 reverse transcriptase can induce long range conformational changes.

D. Stuart, R. Esnouf, A. Hopkins, 1998, Proceedings of the National Academy of Sciences of the United States of America.

Glycoprotein Structural Genomics: Solving the Glycosylation Problem

David J. Harvey, David I. Stuart, Raymond J. Owens, 2007, Structure.

Allosteric Inhibitors against HIV-1 Reverse Transcriptase: Design and Synthesis of MKC-442 Analogues Having an Ω-Functionalized Acyclic Structure

D. Stuart, A. Hopkins, D. Stammers, 1998, Antiviral chemistry & chemotherapy.

Complexes of HIV-1 reverse transcriptase with inhibitors of the HEPT series reveal conformational changes relevant to the design of potent non-nucleoside inhibitors.

Richard T. Walker, David I. Stuart, Robert M. Esnouf, 1996, Journal of medicinal chemistry.

The crystal structure of the catalytic domain of human urokinase-type plasminogen activator.

C. Ponting, C. Dobson, D. Stuart, 1995, Structure.

Structural basis of superantigen action inferred from crystal structure of toxic-shock syndrome toxin-1

D. Stuart, K. Acharya, E. Jones, 1994, Nature.

Efficacy of a Plasmodium vivax Malaria Vaccine Using ChAd63 and Modified Vaccinia Ankara Expressing Thrombospondin-Related Anonymous Protein as Assessed with Transgenic Plasmodium berghei Parasites

O. Billker, E. Jones, A. Hill, 2013, Infection and Immunity.

Cells under siege: Viral glycoprotein interactions at the cell surface

D. Stuart, E. Jones, T. Bowden, 2011, Journal of structural biology.

Improving the representativeness of UK’s national COVID-19 Infection Survey through spatio-temporal regression and post-stratification

K. Lythgoe, D. Bonsall, T. House, 2023, medRxiv.